ESR2 and myeloid sarcoma: For example, ERβ ligand treatment induced neuroprotection in the MS preclinical model through an effect in CD11c+ cells of the microglia/macrophage lineage, and this was not mutually exclusive of an additional role of ERβ in Olig1+ cells of oligodendrocyte lineage59,80.